Work

368MO Fatty acid synthase inhibitor TVB-2640 with bevacizumab in recurrent glioblastoma

Year: 2020

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2020.08.477

Authors: W. Kelly, J. Michalek, A.E. Diaz Duque, V. Madhusudanannair, L. Caflisch, B. Konkel, J. Floyd, A. Brenner

Institutions: The University of Texas at San Antonio Health Science Center, Mays Cancer Center at UT Health San Antonio

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3088572425

FWCI: 0.33

Cites:

Cited by: 3

Related to: 10